Literature DB >> 23484658

[Prescription of psychotropic medicines to pregnant women in Nord-Pas-de-Calais, France].

Thierry Danel1, Laurent Plancke, Alina Amariei, Emmanuel Benoit, Sophie Gautier, Corinne Capele, Guillaume Vaiva.   

Abstract

AIM: Prescription of psychotropic medicines carries risks to pregnancy. It is therefore appropriate to measure the prescription rate of these compounds in pregnant women.
METHOD: We studied the prescription rate for psychotropic agents to pregnant women from the Cnamts medicines reimbursement data and we compared this to prescriptions in non-pregnant women in the same age group.
RESULTS: There is a fall in the use of psychotropic agents in women during pregnancy compared to a non-pregnant population of the same age. Pregnant women receive 2.17 times less psychotropic agents. Nevertheless, approximately one out of every twenty women is prescribed a proprietary product with known risk to the neonate and four out of a thousand are prescribed a proprietary product which carries a risk of malformation during the first trimester.
CONCLUSION: Medical practice takes account of embryo-fetal risk in prescribing psychotropic agents in general although more communication is needed about the risk of some compounds during pregnancy.
© 2013 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23484658     DOI: 10.2515/therapie/2013005

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  1 in total

1.  The multifaceted question of the prescription of antidepressants during pregnancy.

Authors:  Gisèle Apter; Emmanuel Devouche
Journal:  Shanghai Arch Psychiatry       Date:  2013-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.